Oncotarget

Corrections:

Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells

PDF  |  How to cite

Oncotarget. 2018; 9:32401-32401. https://doi.org/10.18632/oncotarget.26018

Metrics: PDF 910 views  |   ?  

Christian Schütz1,4, Juan Carlos Varela2, Karlo Perica1, Carl Haupt1, Mathias Oelke1,3 and Jonathan P. Schneck1

1 Institute of Cell Engineering and Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA
2 Division of Hematology, Department of Medicine, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, Maryland, USA
3 NexImmune Inc., Gaithersburg, Maryland, USA
4 Current address: Division of Immunology, Paul-Ehrlich-Institut, Langen, Germany

Published: August 17, 2018

This article has been corrected: The correct funding information is given below:

FUNDING

This work was in part supported by German Cancer Foundation (Grant no. 70112372), German Research Foundation (SCHU 2681/1-1), HERA Women’s Cancer Foundation OSB1 Grant (C.S.) and the National Institutes of Health (P01-AI072677, R01- CA108835 and R21-CA185819), TEDCO/Maryland Innovation Initiative and Neximmune, Inc. MD Biotech Center (J.P.S.).

Original article: Oncotarget. 2016; 7:68503-68512. DOI: https://doi.org/10.18632/oncotarget.11785.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 26018